Elixirgen Therapeutics, Inc.
Reimagine the Power of RNA
13 employees · est. 2017 · Baltimore, United States
Biosplice Therapeutics
Restore health by delivering first-in-class therapies that harness alternative splicing
37 employees · est. 2008 · San Diego, United States
Biosplice Therapeutics is the older company (2017 vs 2008).
Side-by-Side Comparison
| Metric | Elixirgen Therapeutics, Inc. | Biosplice Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2008 older |
| Headquarters | ||
| Headquarters | Baltimore, United States | San Diego, United States |
| Employees | ||
| Employees | 13 | 37 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series Unknown | Grant |
| Total Funding | ||
| Total Funding | $25.91M | $778.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 6 |
| Services | ||
| Services | Not tracked yet | Therapeutic Modulation of Alternative Splicing |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Osteoarthritis, Cancer, Neurological Disorders, and Diabetes |
| Taxonomy | ||
| Taxonomy | RNA Therapeutics, MRNA Technology, Cell And Gene Therapies, Rare And Genetic Diseases, Aging-related Disorders, Duchenne Muscular Dystrophy, C-srRNA™ Technology, Telomere Biology Disorders, Stem Cell Biology, Regenerative Medicine, Johns Hopkins Science + Technology Park, Biotechnology Company, Intellectual Property, Drug Development, Clinical-stage | Medical Research, Therapeutics Development, Regenerative Medicine, Oncology, Degenerative Diseases, Alternative Splicing, Wnt Pathway Modulation, Small Molecule Therapeutics, Clinical Development, Tissue-Level Regeneration, Alzheimer's Disease, Pre-mRNA Splicing, CLK/DYRK Kinases, Regenerative Pathways |
| Website | ||
| Website | elixirgentx.com | biosplice.com |
About Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. is a biotechnology startup that is making significant strides in the field of RNA therapeutics. The company's focus lies in developing innovative therapies, including cell and gene therapies, to address a wide range of diseases such as rare and genetic disorders, as well...
About Biosplice Therapeutics
Biosplice Therapeutics, founded in 2008 and headquartered in the United States, is dedicated to restoring health by delivering pioneering therapies that leverage alternative splicing. The company's focus on small-molecule therapeutics, rooted in the groundbreaking science of alternative pre-mRNA spl...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Elixirgen Therapeutics, Inc. and Biosplice Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Elixirgen Therapeutics... and Biosplice Therapeutics — by email.
Frequently Asked Questions
Compare Elixirgen Therapeutics, Inc. with someone else
Start typing a company name or domain.